About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 2802 record(s)
Req # A-2016-001765
Adverse Drug Reactions (ADRs) for Januvia. Report numbers: 000515923, 000517943, 000521395, 000527882, 000532798, 000535465, 000536541, 000521160, 000520008, 000541654, 000544841, 000557240.Organization: Health Canada
November 2022
Req # A-2019-001368
Adverse Drug Reactions (ADRs). Report numbers: E2B_02064069, E2B_01368705, E2B_01774271, E2B_00250375, E2B_02019052 000719384, 000719727, E2B_02264938, E2B_02014914, E2B_02015860, 000714205, E2B_02067447.Organization: Health Canada
November 2022
Req # A-2019-001372
Adverse Drug Reactions (ADRs). Report numbers: 000728086, E2B_02691221, E2B_02713428.Organization: Health Canada
November 2022
Req # A-2019-001637
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-116095-291.Organization: Health Canada
November 2022
Req # A-2020-000151
Adverse Drug Reactions (ADRs). Report numbers: E2B_02266431, E2B_00951471, 000725726, 000723232.Organization: Health Canada
November 2022
Req # A-2020-001281
Adverse Drug Reactions (ADRs). Report numbers: E2B_02685978, E2B_02685986, E2B_02686588, E2B_02686677, E2B_02687630, E2B_02688263, E2B_02688836, E2B_02689853, E2B_02690537, E2B_02690569, E2B_02691221, E2B_02691505, E2B_02692185, E2B_02692580,…Organization: Health Canada
November 2022
Req # A-2020-001356
Adverse Drug Reactions (ADRs). Report numbers: E2B_02835120, E2B_02835148, E2B_02835620, E2B_02835912, E2B_02835946, E2B_02835988, E2B_02836268, E2B_02836291, E2B_02836616, E2B_02836632, E2B_02836972, E2B_02837799, E2B_02838557, E2B_02838694,…Organization: Health Canada
November 2022
Req # A-2020-001365
Adverse Drug Reactions (ADRs). Report numbers: E2B_02760241, E2B_02761173, E2B_02761174, E2B_02761176, E2B_02761767, E2B_02761768, E2B_02761808, E2B_02762226, E2B_02762232, E2B_02762233, E2B_02762235, E2B_02762236, E2B_02762237, E2B_02762243,…Organization: Health Canada
November 2022
Req # A-2020-001805
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115890-813.Organization: Health Canada
November 2022
Req # A-2020-001808
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-118199-773.Organization: Health Canada
November 2022